Beit Jala Pharmaceutical Co (XPAE:BJP) Market Cap: JOD0.00 Mil (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Beit Jala Pharmaceutical Co Market Cap?

Beit Jala Pharmaceutical Co XPAE:BJP Market Cap is JOD0.00 Mil as of Aug. 29, 2026. The stock has 1 warning sign investors should review.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Beit Jala Pharmaceutical Co's share price for the quarter that ended in . 20 was JOD. Beit Jala Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in . 20 was 0.00 Mil. Therefore, Beit Jala Pharmaceutical Co's market cap for the quarter that ended in . 20 was JOD Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Beit Jala Pharmaceutical Co's Enterprise Value for Today is JOD0.00 Mil.

Beit Jala Pharmaceutical Co  (XPAE:BJP) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Beit Jala Pharmaceutical Co Market Cap Related Terms

Beit Jala Pharmaceutical Co Market Cap Historical Data

* Premium members only.

The historical data trend for Beit Jala Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beit Jala Pharmaceutical Co Market Cap Chart

Beit Jala Pharmaceutical Co Annual Data
Trend
Market Cap

Beit Jala Pharmaceutical Co Semi-Annual Data
Market Cap

XPAE:BJP vs : Market Cap Comparison

For the Biotechnology subindustry, Beit Jala Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beit Jala Pharmaceutical Co Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beit Jala Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Beit Jala Pharmaceutical Co's Market Cap falls into.


Beit Jala Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Beit Jala Pharmaceutical Co's Market Cap for the fiscal year that ended in . 20 is calculated as

Market Cap (A: . 20 )=Share Price (A: . 20 )*Shares Outstanding (EOP) (A: . 20 )
=JOD*
=JOD

Beit Jala Pharmaceutical Co's Market Cap for the quarter that ended in . 20 is calculated as

Market Cap (Q: . 20 )=Share Price (Q: . 20 )*Shares Outstanding (EOP) (Q: . 20 )
=JOD*0
=JOD

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of JOD0.00 Mil mean?
Beit Jala Pharmaceutical Co (XPAE:BJP) has a Market Cap of JOD0.00 Mil as of Aug. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Beit Jala Pharmaceutical Co and its competitors.
Is Beit Jala Pharmaceutical Co's Market Cap too high?
Beit Jala Pharmaceutical Co's current Market Cap is JOD0.00 Mil.
How does Beit Jala Pharmaceutical Co's Market Cap compare to ?
Beit Jala Pharmaceutical Co's Market Cap of JOD0.00 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 122.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 122.85, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Beit Jala Pharmaceutical Co and its competitors. For the Biotechnology industry, the median Market Cap is 122.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beit Jala Pharmaceutical Co's current Market Cap is JOD0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beit Jala Pharmaceutical Co stock overvalued right now?
Beit Jala Pharmaceutical Co (XPAE:BJP) has a current Market Cap of JOD0.00 Mil. The current Market Cap is JOD0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Beit Jala Pharmaceutical Co (XPAE:BJP), the current Market Cap is JOD0.00 Mil as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beit Jala Pharmaceutical Co Business Description

Comparable Companies
Address 81, Al-Madares Street, Beit Jala, West Bank, Beit Jala, PSE, 97300
Beit Jala Pharmaceutical Co is a manufacturer of pharmaceutical products. The company's products include tablets, capsules, powders, syrups, solutions, oral drops, creams, gels, lotions, medicated shampoo, suppositories and ointments.